peptide wiki

Semax

aka Semax (ACTH(4-10) analog, Met-Glu-His-Phe-Pro-Gly-Pro)

Nootropic / Cognitive

Mechanism

Semax is a synthetic heptapeptide derived from ACTH(4-10). It is registered as a drug in Russia (1994) for acute ischemic stroke, asthenic states, and optic nerve disease; it is not FDA-approved.

Identification

CAS number80714-61-0
Molecular formulaC37H51N9O10S
SequenceMEHFPGP
Typical dose300–1000 mcg/day intranasal or subcutaneous; research protocols range from 300 mcg to 1200 mcg/day
Half-life~2–3 minutes (plasma); CNS effects persist hours to days via direct olfactory/trigeminal delivery

Vendors selling Semax

VendorSizePriceListed purityTrust
Peptide Partners 20 mg $60.00 99
Glacier Aminos 20 mg $81.99 99
Glacier Aminos 10 mg $40.99 99
Moglabs 5 mg $24.00 96
Moglabs 5 mg $36.00 96
Crush Research 15 mg 95
Orbitrex Peptides 10 mg $29.99 95
Profound Aminos 10 mg $59.00 95
Ion Peptide $49.00 95
Licensed Peptides 50 mg $129.99 95
Licensed Peptides 30 mg $76.99 95
Prime Peptides 10 mg $50.00 95
Peptide Tech 5 mg $33.99 94
Mile High Compounds $39.99 94
Mile High Compounds $89.99 94
Forge Performance Co. 10 mg $40.00 94
Amino Club $29.99 93
Riptide Wellness $47.99 92
Hydro Research Peptides 10 mg $0.35 91
Skye Peptides 30 mg $69.00 90
Peptidology 10 mg $79.99 89
Peptidology 27 mg $79.99 89
Peptidology 10 mg $38.00 89
Peptide Plugs 10 mg $40.00 89
Sunrise Bioresearch 50 mg $129.86 88
Sunrise Bioresearch 10 mg $26.23 88
Qihang Peptide 87
EZ Peptides 10 mg $88.00 85
EZ Peptides 10 mg $44.00 85
Simple Peptide 5 mg $60.00 85
Simple Peptide 10 mg $55.00 85
Peptidegurus 30 mg 84
Peptidegurus 30 mg 84
Ascension Peptides 10 mg $59.99 84
Reta Peptide 83
Cocer Peptides 10 mg $60.00 82
Cocer Peptides 50 mg $320.00 82
Cocer Peptides 10 mg $60.00 82
MedGe Peptides 30 mg 82
Blank Peptides 10 mg $50.00 81
OROS Research 9 mg 79
OROS Research 30 mg 79
Texpeptide 10 mg $60.00 70
Crystal Peptides 5 mg $24.99 66
Crystal Peptides 10 mg $44.99 66
Qing Li Peptide 63
Certified Peptides 10 mg $54.00 62
Nox Amino 10 mg $45.00 55
Peptiatlas 51
Taishijie 51
Taikangbio 50
Hkuppeptide 5 mg $10.00 50
Hkuppeptide 10 mg $10.00 50
MEI-PEPETIDE 5 mg $30.00 48
DongCheng Peptide 46
Mandy 5 mg $33.00 43
HongDa Peptide $57.00 43
zztai Peptide Ltd 43
MJT peptides 5 mg $46.00 39
Cernum Biosciences 5 mg $43.99
Cernum Biosciences 10 mg $83.99
NG Peptide 10 mg $35.00
AMC Essentials 10 mg $39.99
Alpha Omega 5 mg $60.00
Alpha Omega 10 mg $55.00
Arcane Peptides 5 mg $30.00
Atomik Labz 30 mg $98.00
Atomik Labz 30 mg $90.00
Atomik Labz 10 mg $46.00
Atomik Labz 10 mg $35.00
Biotech Peptides 25 mg $53.00
Bulk Peptides 5 mg $140.00
Core Peptides 25 mg $63.00
Felix Chemical Supply 10 mg $34.99
Flawless Compounds
Flawless Compounds 50 mg
Genetic Peptide 30 mg $75.00
Kimera Chems $26.99
Lumi Peptides $35.00
Modern Research Peptides $21.99
Nextech Labs 10 mg $50.00
Nextech Labs 10 mg $45.00
Nova Peptides $84.99
Nova Peptides 10 mg $34.99
Oasis Labs 10 mg $48.50
Oneday Compounds 10 mg $34.99
Paramount Peptides 30 mg $243.00
Paramount Peptides 30 mg $648.00
Paramount Peptides 30 mg $60.00
Peptide Crafters 10 mg $35.00
Peptira $49.00
Pepvida Labs 10 mg $31.39
Puratek Peptides 10 mg $32.95
Solution Peptides 30 mg $98.00
Solution Peptides 30 mg $90.00
Solution Peptides 10 mg $46.00
Solution Peptides 10 mg $35.00
Soma Peptides $129.00
Soma Peptides 5 mg $83.00
Soma Peptides $209.00
Soma Peptides 10 mg $51.00
Southern Aminos 10 mg $44.25
Welli Labs $29.99
Welli Labs $39.99
Wellness Peptides $32.00

Research

Digitally Guided Hybrid Maxillary Expansion with Supragingival Mandibular Miniplates for Class III Correction in Late Adolescents: A Pilot Clinical Study
Arcos I, Walter A, Marc T, Clusellas N, Puigdollers A. · Journal of clinical medicine (2026) ·

Background: Management of skeletal Class III malocclusion of maxillary origin in late adolescence remains challenging, as conventional tooth-borne orthopedic approaches show reduced effectiveness at advanced stages of skeletal maturation.

source →
Multi-Layer Magnetic Shields Based on Fe-Based Nanocrystalline and Co-Based Amorphous Ribbons
Liang Y, Liu B, Ma H, Pan L, He A, Dong Y, Man Q, Li J. · Materials (Basel, Switzerland) (2026) ·

We constructed a multi-layer composite magnetic shield composed of Fe-based nanocrystalline (FN) and Co-based amorphous (CA) ribbons, and focused on the influence of the number of layers and their arrangement on the shielding effectiveness (SE).

source →
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging
Mavrych V, Shypilova I, Bolgova O. · Frontiers in aging (2026) · review

Background Peptide therapeutics represent an emerging frontier in gerontological medicine, targeting fundamental hallmarks of aging including metabolic dysfunction, telomere attrition, tissue repair impairment, and hormonal decline.

source →
[Effect of a combined physiotherapeutic approach on changes in functional parameters after endovitreal surgery of rhegmatogenous retinal detachment with a favorable anatomical outcome]
Sheludchenko VM, Matyushchenko AG, Alharki L, Baryshev KV, Balkar SS, Makarova MA, Alenov MM, Harki YA. · Vestnik oftalmologii (2026) ·

Objective The study evaluated the effect of combined physiotherapeutic treatment (CPT) on changes in functional retinal parameters after endovitreal surgery of rhegmatogenous retinal detachment (RRD) with a favorable anatomical outcome.

source →
Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives
Renke G, Chinellato L. · International journal of molecular sciences (2026) · review

Therapeutic peptides are short chains of amino acids used to treat metabolic and endocrine conditions such as obesity and type 2 diabetes.

source →
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
Rahman OF, Lee SJ, Seeds WA. · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews (2026) · review

Therapeutic peptides are emerging as promising adjuncts in the management of orthopaedic injuries, grounded in their ability to modulate molecular signaling networks central to cellular medicine.

source →
The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease
Radchenko AI, Kuzubova EV, Apostol AA, Mitkevich VA, Andreeva LA, Limborska SA, Stepenko YV, Shmigerova VS, Solin AV, Korokin MV, Pokrovskii MV, Myasoedov NF, Makarov AA. · Acta naturae (2025) · animal

Alzheimer's disease, first described over a century ago, is currently among the most common neurodegenerative diseases whose significance is increasingly growing with the aging of populations.

source →
The Effect of Peptide Semax, an ACTH(4-10) Analogue, on Intracellular Calcium Dynamics in Rat Brain Neurons
Kolbaev SN, Sharonova IN, Skrebitsky VG. · Bulletin of experimental biology and medicine (2025) · animal

We studied the effects of Semax on spontaneous fluctuations of intracellular calcium ion concentration [Ca 2+ ] i in pyramidal neurons on hippocampal slices and on proton-induced increase in [Ca 2+ ] i in cerebellar granule cells in cerebellar slices.

source →
Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice
Liu R, Chen Y, Huang H, Li X, Lv J, Jiang L, Jiang H, Wu C, Chen W, Xu H, Zhu Z, Cai H, Xiao J, Yin L, Ni W. · British journal of pharmacology (2025) · animal

Background and purpose Lysosomal membrane permeabilization (LMP) is exacerbated following spinal cord injury (SCI), leading to increased neuronal cell death. Ubiquitination may affect LMP by regulating the stability and functionality of lysosomal membranes.

source →
Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing
Tomasello MF, Di Rosa MC, Naletova I, Sciacca MFM, Giuffrida A, Maccarrone G, Attanasio F. · Bioinorganic chemistry and applications (2025) · in-vitro

Alzheimer's disease (AD) is the most common neurodegenerative disorder associated with cognitive decline and loss of memory.

source →
Genes That Associated with Action of ACTH-like Peptides with Neuroprotective Potential in Rat Brain Regions with Different Degrees of Ischemic Damage
Filippenkov IB, Shpetko YY, Ales DA, Stavchansky VV, Denisova AE, Yuzhakov VV, Fomina NK, Gubsky LV, Andreeva LA, Myasoedov NF, Limborska SA, Dergunova LV. · International journal of molecular sciences (2025) · animal

In the treatment of ischemic stroke, an innovative approach is the use of neuroprotective compounds. Natural peptides, including adrenocorticotropic hormone (ACTH), can serve as the basis for such drugs.

source →
ACTH-like Peptides Compensate Rat Brain Gene Expression Profile Disrupted by Ischemia a Day After Experimental Stroke
Filippenkov IB, Shpetko YY, Stavchansky VV, Denisova AE, Gubsky LV, Andreeva LA, Myasoedov NF, Limborska SA, Dergunova LV. · Biomedicines (2024) · animal

Background: Ischemic stroke results from a disruption of cerebral blood flow. Adrenocorticotropic hormone (ACTH) serves as the basis for the creation of synthetic peptides as neuroprotective agents for stroke therapy.

source →